ED Raids Srisan Pharma After Children’s Deaths Linked to Toxic Cough Syrup
Massive Action Taken
The Enforcement Directorate (ED) has conducted raids at seven locations linked to Srisan Pharma in Chennai and also at residences of tamil Nadu Drug Control Department officials.
Raids were conducted under the Prevention of Money Laundering Act (PMLA).
Triggering Incident
Over 20 children died in madhya pradesh and rajasthan recently after consuming Coldrif cough syrup, manufactured by Srisan Pharma.
The cause of death was reported as kidney failure, linked to toxic ingredients in the syrup.
Toxic Ingredient Identified
Tests revealed the presence of lethal levels of diethylene glycol in the cough syrup.
Diethylene glycol is a toxic industrial chemical, used in antifreeze, and is banned in many regions due to its deadly effects on the kidneys.
ED’s criminal Case
The ED registered a criminal case after receiving police complaints from madhya pradesh and tamil Nadu.
Srisan Pharma owner G. Ranganathan was arrested on october 9 in connection with the case.
Regulatory Failures Exposed
Investigations by the Central drugs Standard Control
Organization (CDSCO) revealed
Poor infrastructure at Srisan Pharma.
Repeated safety violations.
Negligence by Tamil Nadu FDA in monitoring and enforcement.
The company had been operating for over a decade despite these failures.
Action Against Officials
Madhya Pradesh
Two drug inspectors and a deputy FDA director suspended.
State Drug Controller transferred.
A doctor in Chhindwara arrested for alleged negligence.
Tamil Nadu
Two senior state drug inspectors suspended.
Srisan Pharma’s operations shut down.
Ongoing Investigations
Both state and central agencies continue to investigate possible regulatory corruption and systemic oversight failures.
The case raises serious concerns over pharmaceutical safety and accountability in India.
click and follow Indiaherald WhatsApp channel